Form 4: Astrana Health Chief Accounting Officer Reports Share Transaction
SEC Form 4 Filing
John Vong, Chief Accounting Officer of Astrana Health, Inc., reported a transaction involving the surrender of 636 shares to cover tax obligations related to vesting restricted stock.
Summary
- John Vong, the Chief Accounting Officer of Astrana Health, Inc., filed a Form 4 indicating a transaction on November 12, 2024.
- The transaction involved the disposal of 636 common stock shares at a price of $42.91 per share.
- These shares were surrendered to cover tax withholding obligations associated with the vesting of restricted stock.
- Following the transaction, Vong beneficially owns 17,654 shares of common stock.
- This total includes 12,002 shares of restricted stock that will vest over time, and 76 shares acquired through the Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document is a routine filing of a share transaction related to executive compensation, and does not indicate any positive or negative sentiment.
Industry Context
This is a routine filing related to executive compensation and does not indicate any unusual activity within the company or the broader industry.
Comparison to Industry Standards
- Form 4 filings are standard practice for company insiders and are common across all publicly traded companies.
- The vesting schedules for restricted stock are typical for executive compensation packages.
- The use of shares to cover tax obligations is a common practice.
Stakeholder Impact
- The transaction has a minor impact on the total number of shares outstanding.
- The vesting of restricted stock is part of the company's compensation strategy for its executives.
Key Dates
| Date | Description |
|---|---|
| 11/12/2024 | Date of the share transaction. |
| 11/13/2024 | Date the form was signed. |
| 07/11/2025 | First vesting date for some restricted stock. |
| 07/11/2026 | Second vesting date for some restricted stock. |
| 11/30/2024 | First vesting date for other tranches of restricted stock. |
| 05/12/2025 | First vesting date for other tranches of restricted stock. |
Keywords
Form 4, Astrana Health, Share Transaction, Beneficial Ownership, Restricted Stock, Tax Withholding, Employee Stock Purchase Plan, John Vong, Chief Accounting Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.